Yoshiyuki Iida

Shimonagakubo, 4118777, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Clinicopathological Features of Buccal Squamous Cell Carcinoma with Focus on Patients Who Never Smoke and Never Drink.

Clinicopathological Features of Buccal Squamous Cell Carcinoma with Focus on Patients Who Never Smoke and Never Drink.

Journal: International archives of otorhinolaryngology

Published: February 14, 2022

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.

Journal: International journal of clinical oncology

Published: April 22, 2021

Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?

Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?

Journal: International journal of clinical oncology

Published: December 20, 2020

Molecular profile of a pleomorphic adenoma of the hard palate: A case report.

Molecular profile of a pleomorphic adenoma of the hard palate: A case report.

Journal: Medicine

Published: July 25, 2020

Chemoradiotherapy for high-risk stage II laryngeal cancer.

Chemoradiotherapy for high-risk stage II laryngeal cancer.

Journal: International journal of clinical oncology

Published: March 08, 2020

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.

Journal: Cancer

Published: February 10, 2020

Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.

Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.

Journal: International journal of clinical oncology

Published: August 28, 2019

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Journal: International journal of clinical oncology

Published: September 02, 2018

Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.

Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.

Journal: Head and neck pathology

Published: August 29, 2018

Reply to: Preventive role of ramelteon and suvorexant for postoperative delirium after pharyngolaryngectomy with esophagectomy.

Reply to: Preventive role of ramelteon and suvorexant for postoperative delirium after pharyngolaryngectomy with esophagectomy.

Journal: Esophagus : official journal of the Japan Esophageal Society

Published: March 05, 2018

Depth of invasion in superficial oral tongue carcinoma quantified using intraoral ultrasonography.

Depth of invasion in superficial oral tongue carcinoma quantified using intraoral ultrasonography.

Journal: The Laryngoscope

Published: January 04, 2018

Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.

Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.

Journal: Oncotarget

Published: June 16, 2017

Showing 1-12 of 29

Last Updated: 09/26/2026